A 42-year-old woman from Mumbai with chronic kidney disease (eGFR 15 mL/min/1.73m²) is admitted with severe muscle cramps and cardiac palpitations. Serum potassium is 6.9 mEq/L. Her physician administers intravenous calcium gluconate immediately. Which of the following best describes the mechanism by which calcium gluconate improves cardiac excitability?

Explanation

## Mechanism of Calcium Gluconate in Hyperkalemia ### The Problem: Hyperkalemia and Cardiac Instability **Key Point:** In hyperkalemia, elevated extracellular K⁺ depolarizes the resting membrane potential (RMP), bringing it dangerously close to the threshold potential. This narrows the **safety margin** — the voltage difference between RMP and threshold — making the heart prone to spontaneous depolarization and fatal arrhythmias. ### Normal Cardiac Electrophysiology - **Resting membrane potential (RMP):** −80 to −90 mV in ventricular myocytes - **Threshold potential:** approximately −60 to −65 mV - **Safety margin:** ~20–25 mV (the difference) When K⁺ₒᵤₜ is normal (~5 mEq/L), this large margin prevents ectopic firing. ### Effect of Hyperkalemia Using the Nernst equation for K⁺: $$E_K = 61 \log \frac{[K^+]_{in}}{[K^+]_{out}}$$ When K⁺ₒᵤₜ rises to 6.9 mEq/L, the K⁺ gradient decreases, and RMP depolarizes to approximately −60 to −65 mV — **approaching or at threshold**. The safety margin collapses to near zero, causing: - Peaked T waves (early repolarization) - Prolonged PR interval - Wide QRS - Risk of ventricular fibrillation ### How Calcium Gluconate Restores Safety Margin **High-Yield:** Calcium does **not** lower serum potassium or change RMP. Instead, it **raises the threshold potential** (makes it more negative/hyperpolarized). **Mechanism:** 1. Calcium binds to the **outer surface of voltage-gated sodium channels** in the cardiac membrane. 2. This binding stabilizes the channel structure and shifts the voltage-dependence of channel opening to more negative potentials. 3. The **threshold potential becomes more negative** (e.g., from −60 mV to −70 mV). 4. Even though RMP is still depolarized (e.g., −65 mV), the new threshold is now **more negative than the RMP**, restoring the safety margin. 5. The cell is no longer on the brink of spontaneous depolarization. ### Timeline of Effects | Intervention | Onset | Mechanism | Effect on RMP | Effect on Threshold | |--------------|-------|-----------|----------------|---------------------| | **Calcium gluconate** | 1–3 min | Stabilizes Na⁺ channels | No change | ↑ (more negative) | | Insulin + glucose | 10–20 min | Shifts K⁺ intracellularly | ↓ (becomes more negative) | No change | | β₂-agonists | 5–10 min | Shift K⁺ intracellularly | ↓ (becomes more negative) | No change | | Diuretics/dialysis | Hours | Remove K⁺ from body | ↓ (becomes more negative) | No change | **Clinical Pearl:** Calcium is the **only acute intervention** that directly affects the threshold; all other treatments lower serum K⁺ to restore the RMP. Calcium buys time while definitive K⁺-lowering therapies take effect. ### ECG Response Within 1–3 minutes of calcium gluconate: - Peaked T waves may persist (RMP still depolarized) - **QRS widens less** (improved conduction safety) - **Arrhythmia risk decreases** (threshold restored) - ST segment normalizes ```mermaid flowchart TD A[Hyperkalemia<br/>K+ = 6.9 mEq/L]:::outcome --> B[RMP depolarizes<br/>e.g. -65 mV]:::outcome B --> C[Threshold unchanged<br/>e.g. -60 mV]:::outcome C --> D[Safety margin collapses<br/>RMP ≈ Threshold]:::urgent D --> E[Risk of spontaneous<br/>depolarization & VF]:::urgent F[Calcium gluconate IV]:::action --> G[Binds Na+ channel<br/>outer surface]:::action G --> H[Threshold becomes<br/>more negative<br/>e.g. -70 mV]:::action H --> I[Safety margin restored<br/>RMP -65 mV vs Threshold -70 mV]:::outcome I --> J[Arrhythmia risk ↓<br/>Cardiac stability ↑]:::outcome D -.->|Definitive treatment| K[Insulin + glucose<br/>β₂-agonists<br/>Dialysis]:::action K --> L[K+ lowered<br/>RMP normalizes]:::outcome ```